Antimo Gioiello

Perugia, 06123, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 76 publications

Lighting Up Gut Dysbiosis: Red-Shifted Whole-Cell Bioluminescence Enables Functional Sensing of Bile Salt Hydrolase Activity in Human Feces.

Lighting Up Gut Dysbiosis: Red-Shifted Whole-Cell Bioluminescence Enables Functional Sensing of Bile Salt Hydrolase Activity in Human Feces.

Journal: ACS sensors

Published: June 12, 2026

Advanced Synthetic Methods in Modern Medicinal Chemistry.

Advanced Synthetic Methods in Modern Medicinal Chemistry.

Journal: Journal of medicinal chemistry

Published: May 28, 2026

Development of Biphenyl-Substituted Uracil-Based Hydroxamic Acids (UBHAs) as Potent HDAC Inhibitors with Pro-Apoptotic Activity in Leukemia and Prostate Cancer Cells.

Development of Biphenyl-Substituted Uracil-Based Hydroxamic Acids (UBHAs) as Potent HDAC Inhibitors with Pro-Apoptotic Activity in Leukemia and Prostate Cancer Cells.

Journal: Journal of medicinal chemistry

Published: April 30, 2026

Development of Biphenyl-Substituted Uracil-Based Hydroxamic Acids (UBHAs) as Potent HDAC Inhibitors with Pro-Apoptotic Activity in Leukemia and Prostate Cancer Cells.

Development of Biphenyl-Substituted Uracil-Based Hydroxamic Acids (UBHAs) as Potent HDAC Inhibitors with Pro-Apoptotic Activity in Leukemia and Prostate Cancer Cells.

Journal: Journal of medicinal chemistry

Published: April 30, 2026

Garcinoic acid: A vitamin E metabolite-mimetic scaffold linking nuclear receptor pharmacology to inflammatory signaling and biomimetic drug discovery.

Garcinoic acid: A vitamin E metabolite-mimetic scaffold linking nuclear receptor pharmacology to inflammatory signaling and biomimetic drug discovery.

Journal: Pharmacology & therapeutics

Published: April 18, 2026

Lipid nanoparticles for Ursodeoxycholic Acid Delivery: A Strategy for Topical Applications.

Lipid nanoparticles for Ursodeoxycholic Acid Delivery: A Strategy for Topical Applications.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: April 08, 2026

The rare bile acid isoallolithocholic acid (IALCA) is an EphA2 antagonist sparing FXR and TGR5 receptors.

The rare bile acid isoallolithocholic acid (IALCA) is an EphA2 antagonist sparing FXR and TGR5 receptors.

Journal: Biochemical pharmacology

Published: December 18, 2025

Novel tyrosinol-based chiral stationary phase for the separation of tetracyclic quinolines active as PXR agonists: Investigating the enantiorecognition mechanism through molecular dynamics.

Novel tyrosinol-based chiral stationary phase for the separation of tetracyclic quinolines active as PXR agonists: Investigating the enantiorecognition mechanism through molecular dynamics.

Journal: Analytica chimica acta

Published: October 28, 2025

Structure-Based Discovery of Obeticholic Acid Derivatives as Novel Farnesoid X Receptor Partial Agonists with Improved Selectivity and Reduced Off-Target Effects.

Structure-Based Discovery of Obeticholic Acid Derivatives as Novel Farnesoid X Receptor Partial Agonists with Improved Selectivity and Reduced Off-Target Effects.

Journal: ChemMedChem

Published: October 24, 2025

Novel Sulfonium Reagents for the Modular Synthesis of Spiro[2.3]Hexanes and Heteroatom-Containing Analogues: Synthesis, Application, and Evaluation as Bioisosteres.

Novel Sulfonium Reagents for the Modular Synthesis of Spiro[2.3]Hexanes and Heteroatom-Containing Analogues: Synthesis, Application, and Evaluation as Bioisosteres.

Journal: Angewandte Chemie (International ed. in English)

Published: October 02, 2025

Discovery and development of steroidal enzyme inhibitors as anti-cancer drugs: state-of-the-art and future perspectives.

Discovery and development of steroidal enzyme inhibitors as anti-cancer drugs: state-of-the-art and future perspectives.

Journal: Journal of enzyme inhibition and medicinal chemistry

Published: April 02, 2025

Garcinoic acid enhances inflammation resolution against colitis by activating Nrf2 dependent efferocytosis.

Garcinoic acid enhances inflammation resolution against colitis by activating Nrf2 dependent efferocytosis.

Journal: Free radical biology & medicine

Published: January 31, 2025

Showing 1-12 of 76

Last Updated: 09/26/2026